Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
Apply
Remibrutinib
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step